Clinical Trials on Coccidiosis in New Zealand

Total 16 results

Janssen, LP

Completed

Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

HIV Infections | Cryptosporidiosis

United States
Janssen, LP

Completed

A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS

HIV Infections | Cryptosporidiosis

United States
Stolle Milk Biologic International

Completed

The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea

HIV Infections | Cryptosporidiosis

United States
National Institute of Allergy and Infectious Diseases...
Janssen Pharmaceuticals

Completed

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

HIV Infections | Cryptosporidiosis

United States
Univax Biologics Inc

Completed

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients

HIV Infections | Cryptosporidiosis

United States
Rhone-Poulenc Rorer
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

HIV Infections | Cryptosporidiosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

HIV Infections | Cryptosporidiosis

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients

HIV Infections | Toxoplasmosis, Cerebral

United States
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome

Completed

A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients

HIV Infections | Toxoplasmosis, Cerebral

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection

HIV Infections | Toxoplasmosis, Cerebral

United States
Pfizer
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS

HIV Infections | Toxoplasmosis, Cerebral

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

HIV Infections | Toxoplasmosis, Cerebral

United States
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome; Upjohn

Completed

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

HIV Infections | Toxoplasmosis, Cerebral

United States
Pfizer

Completed

Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

HIV Infections | Cryptosporidiosis

United States
Glaxo Wellcome

Completed

A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine

HIV Infections | Toxoplasmosis, Cerebral

United States, Canada
Scynexis, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)

Coccidioidomycosis | Invasive Pulmonary Aspergillosis | Allergic Bronchopulmonary Aspergillosis | Histoplasmosis | Chronic Pulmonary Aspergillosis | Blastomycosis | Invasive Candidiasis | Recurrent Vulvovaginal Candidiasis | Mucocutaneous Candidiasis | Other Emerging Fungi

United States, Spain, United Kingdom, Austria, Pakistan, Germany, Netherlands, South Africa

Clinical Trials on Coccidiosis in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations